Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health

Alice Ravera, Valentina Carubelli, Edoardo Sciatti, Ivano Bonadei, Elio Gorga, Dario Cani, Enrico Vizzardi, Marco Metra, Carlo Lombardi, Alice Ravera, Valentina Carubelli, Edoardo Sciatti, Ivano Bonadei, Elio Gorga, Dario Cani, Enrico Vizzardi, Marco Metra, Carlo Lombardi

Abstract

The increasing burden of cardiovascular disease (CVD) despite the progress in management entails the need of more effective preventive and curative strategies. As dietary-associated risk is the most important behavioral factor influencing global health, it appears the best target in the challenge against CVD. Although for many years, since the formulation of the cholesterol hypothesis, a nutrient-based approach was attempted for CVD prevention and treatment, in recent years a dietary-based approach resulted more effective in reducing cardiovascular risk worldwide. After the publication of randomized trials on the remarkable effects of the Mediterranean diet and the Dietary Approach to Stop Hypertension (DASH) diet on CVD, new efforts were put on research about the effects of complex dietary interventions on CVD. The purpose of this paper is to review the evidence on dietary interventions in the prevention and disease modification of CVD, focusing on coronary artery disease and heart failure, the main disease responsible for the enormous toll taken by CVD worldwide.

Keywords: DASH; Mediterranean; cardiovascular disease; coronary artery disease; diet; heart failure; hypertension.

Figures

Figure 1
Figure 1
Factors to consider for tailoring dietary interventions in patients with CVD. BMI, Body Mass Index; CV(D), Cardiovascular (Disease).

References

    1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., Das S.R., de Ferranti S., Despres J.P., Fullerton H.J., et al. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation. 2016;133:e38–e360. doi: 10.1161/CIR.0000000000000350.
    1. Townsend N., Nichols M., Scarborough P., Rayner M. Cardiovascular disease in Europe 2015: Epidemiological update. Eur. Heart J. 2015;36:2673–2674. doi: 10.1093/eurheartj/ehv428.
    1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–171.
    1. Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855–2864. doi: 10.1161/hc4701.099488.
    1. Bhupathiraju S.N., Tucker K.L. Coronary heart disease prevention: Nutrients, foods, and dietary patterns. Clin. Chim. Acta. 2011;412:1493–1514. doi: 10.1016/j.cca.2011.04.038.
    1. Witte K.K., Byrom R. Micronutrients for chronic heart failure: End of the road or path to enlightenment? JACC Heart Fail. 2014;2:318–320. doi: 10.1016/j.jchf.2014.04.001.
    1. Konstantinov I.E., Jankovic G.M. Alexander I. Ignatowski: A pioneer in the study of atherosclerosis. Tex. Heart Inst. J. 2013;40:246–249.
    1. Keys A. Diet and the epidemiology of coronary heart disease. J. Am. Med. Assoc. 1957;164:1912–1919. doi: 10.1001/jama.1957.62980170024007e.
    1. Keys A. Coronary heart disease in seven countries, 1970. Nutrition. 1997;13:250–252. doi: 10.1016/S0899-9007(96)00410-8.
    1. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R., Dontas A.S., Fidanza F., Giampaoli S., Jansen A., et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: The seven countries study. Prev. Med. 1995;24:308–315. doi: 10.1006/pmed.1995.1049.
    1. Dyerberg J., Bang H.O. Lipid metabolism, atherogenesis, and haemostasis in Eskimos: The role of the prostaglandin-3 family. Haemostasis. 1979;8:227–233. doi: 10.1159/000214314.
    1. Spigoni V., Lombardi C., Cito M., Picconi A., Ridolfi V., Andreoli R., Anelli N., Gnudi L., Goldoni M., Zavaroni I., et al. n-3 PUFA increase bioavailability and function of endothelial progenitor cells. Food Funct. 2014;5:1881–1890. doi: 10.1039/C3FO60641D.
    1. Page I.H., Stare F.J., Corcoran A.C., Pollack H., Wilkinson C.F., Jr. Atherosclerosis and the fat content of the diet. J. Am. Med. Assoc. 1957;164:2048–2051. doi: 10.1001/jama.1957.62980180004013.
    1. Heidemann C., Schulze M.B., Franco O.H., van Dam R.M., Mantzoros C.S., Hu F.B. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation. 2008;118:230–237. doi: 10.1161/CIRCULATIONAHA.108.771881.
    1. Mozaffarian D., Ludwig D.S. Dietary guidelines in the 21st century—A time for food. JAMA. 2010;304:681–682. doi: 10.1001/jama.2010.1116.
    1. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003;348:2599–2608. doi: 10.1056/NEJMoa025039.
    1. Aravanis C., Corcondilas A., Dontas A.S., Lekos D., Keys A. Coronary heart disease in seven countries. IX. The Greek islands of Crete and Corfu. Circulation. 1970;41:I88–I100. doi: 10.1161/01.CIR.41.4S1.I-88.
    1. Fidanza F., Puddu V., Imbimbo A.B., Menotti A., Keys A. Coronary heart disease in seven countries. VII. Five-year experience in rural Italy. Circulation. 1970;41:I63–I75. doi: 10.1161/01.CIR.41.4S1.I-63.
    1. Eckel R.H., Jakicic J.M., Ard J.D., de Jesus J.M., Miller N.H., Hubbard V.S., Lee I.M., Lichtenstein A.H., Loria C.M., Millen B.E., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 2014;63:2960–2984. doi: 10.1016/j.jacc.2013.11.003.
    1. Trichopoulou A., Kouris-Blazos A., Wahlqvist M.L., Gnardellis C., Lagiou P., Polychronopoulos E., Vassilakou T., Lipworth L., Trichopoulos D. Diet and overall survival in elderly people. BMJ. 1995;311:1457–1460. doi: 10.1136/bmj.311.7018.1457.
    1. Kouris-Blazos A., Gnardellis C., Wahlqvist M.L., Trichopoulos D., Lukito W., Trichopoulou A. Are the advantages of the Mediterranean diet transferable to other populations? A cohort study in Melbourne, Australia. Br. J. Nutr. 1999;82:57–61.
    1. Osler M., Schroll M. Diet and mortality in a cohort of elderly people in a north European community. Int. J. Epidemiol. 1997;26:155–159. doi: 10.1093/ije/26.1.155.
    1. Lasheras C., Fernandez S., Patterson A.M. Mediterranean diet and age with respect to overall survival in institutionalized, nonsmoking elderly people. Am. J. Clin. Nutr. 2000;71:987–992.
    1. Trichopoulou A., Bamia C., Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ. 2009;338:b2337. doi: 10.1136/bmj.b2337.
    1. Knoops K.T., de Groot L.C., Kromhout D., Perrin A.E., Moreiras-Varela O., Menotti A., van Staveren W.A. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: The hale project. JAMA. 2004;292:1433–1439. doi: 10.1001/jama.292.12.1433.
    1. Mitrou P.N., Kipnis V., Thiebaut A.C., Reedy J., Subar A.F., Wirfalt E., Flood A., Mouw T., Hollenbeck A.R., Leitzmann M.F., et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: Results from the NIH–AARP diet and health study. Arch. Intern. Med. 2007;167:2461–2468. doi: 10.1001/archinte.167.22.2461.
    1. Fung T.T., Rexrode K.M., Mantzoros C.S., Manson J.E., Willett W.C., Hu F.B. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation. 2009;119:1093–1100. doi: 10.1161/CIRCULATIONAHA.108.816736.
    1. Perk J., de Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., Albus C., Benlian P., Boysen G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur. Heart. J. 2012;33:1635–1701.
    1. Estruch R., Ros E., Salas-Salvado J., Covas M.I., Corella D., Aros F., Gomez-Gracia E., Ruiz-Gutierrez V., Fiol M., Lapetra J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013;368:1279–1290. doi: 10.1056/NEJMoa1200303.
    1. Appel L.J., van Horn L. Did the predimed trial test a Mediterranean diet? N. Engl. J. Med. 2013;368:1353–1354. doi: 10.1056/NEJMe1301582.
    1. De Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., Guidollet J., Touboul P., Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459. doi: 10.1016/S0140-6736(94)92580-1.
    1. De Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the lyon diet heart study. Circulation. 1999;99:779–785. doi: 10.1161/01.CIR.99.6.779.
    1. Booth J.N., 3rd, Levitan E.B., Brown T.M., Farkouh M.E., Safford M.M., Muntner P. Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the reasons for geographic and racial differences in stroke study) Am. J. Cardiol. 2014;113:1933–1940.
    1. Lopez-Garcia E., Rodriguez-Artalejo F., Li T.Y., Fung T.T., Li S., Willett W.C., Rimm E.B., Hu F.B. The mediterranean-style dietary pattern and mortality among men and women with cardiovascular disease. Am. J. Clin. Nutr. 2014;99:172–180. doi: 10.3945/ajcn.113.068106.
    1. Tuttle K.R., Shuler L.A., Packard D.P., Milton J.E., Daratha K.B., Bibus D.M., Short R.A. Comparison of low-fat versus mediterranean-style dietary intervention after first myocardial infarction (from the heart institute of spokane diet intervention and evaluation trial) Am. J. Cardiol. 2008;101:1523–1530. doi: 10.1016/j.amjcard.2008.01.038.
    1. Force M.T., Montalescot G., Sechtem U., Achenbach S., Andreotti F., Arden C., Budaj A., Bugiardini R., Crea F., Cuisset T., et al. 2013 ESC guidelines on the management of stable coronary artery disease: The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013;34:2949–3003.
    1. Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P., Douglas P.S., Foody J.M., Gerber T.C., Hinderliter A.L., et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2012;60:e44–e164.
    1. Metra M., Zaca V., Parati G., Agostoni P., Bonadies M., Ciccone M., Cas A.D., Iacoviello M., Lagioia R., Lombardi C., et al. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. J. Cardiovasc. Med. (Hagerstown) 2011;12:76–84. doi: 10.2459/JCM.0b013e32834058d1.
    1. Lazzarini V., Bettari L., Bugatti S., Carubelli V., Lombardi C., Metra M., dei Cas L. Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail. Rev. 2012;17:291–303. doi: 10.1007/s10741-011-9253-3.
    1. Carubelli V., Metra M., Lombardi C., Bettari L., Bugatti S., Lazzarini V., dei Cas L. Renal dysfunction in acute heart failure: Epidemiology, mechanisms and assessment. Heart Fail. Rev. 2012;17:271–282. doi: 10.1007/s10741-011-9265-z.
    1. Braunwald E. The war against heart failure: The lancet lecture. Lancet. 2015;385:812–824. doi: 10.1016/S0140-6736(14)61889-4.
    1. Metra M., Bugatti S., Bettari L., Carubelli V., Danesi R., Lazzarini V., Lombardi C., Cas L.D. Can we improve the treatment of congestion in heart failure? Expert Opin. Pharmacother. 2011;12:1369–1379. doi: 10.1517/14656566.2011.557069.
    1. Metra M., Bettari L., Carubelli V., Bugatti S., dei Cas A., del Magro F., Lazzarini V., Lombardi C., dei Cas L. Use of inotropic agents in patients with advanced heart failure: Lessons from recent trials and hopes for new agents. Drugs. 2011;71:515–525. doi: 10.2165/11585480-000000000-00000.
    1. Castrini A.I., Carubelli V., Lazzarini V., Bonadei I., Lombardi C., Metra M. Serelaxin a novel treatment for acute heart failure. Expert Rev. Clin. Pharmacol. 2015;8:549–557. doi: 10.1586/17512433.2015.1073587.
    1. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Böhm M., Dickstein K., Falk V., Filippatos G., Fonseca C., Gomez-Sanchez M.A., et al. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2012;14:803–869.
    1. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Jr., Drazner M.H., Fonarow G.C., Geraci S.A., Horwich T., Januzzi J.L., et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 2013;62:e147–e239. doi: 10.1016/j.jacc.2013.05.019.
    1. Braunwald E. Heart failure. JACC Heart Fail. 2013;1:1–20. doi: 10.1016/j.jchf.2012.10.002.
    1. Nodari S., Manerba A., Vaccari A., Milesi G., Carubelli V., Lazzarini V., Lombardi C., Ettori F., Metra M., dei Cas A. Six-year prognosis of diabetic patients with coronary artery disease. Eur. J. Clin. Invest. 2012;42:376–383. doi: 10.1111/j.1365-2362.2011.02593.x.
    1. Nordmann A.J., Suter-Zimmermann K., Bucher H.C., Shai I., Tuttle K.R., Estruch R., Briel M. Meta-analysis comparing mediterranean to low–fat diets for modification of cardiovascular risk factors. Am. J. Med. 2011;124:841–851. doi: 10.1016/j.amjmed.2011.04.024.
    1. Fung T.T., McCullough M.L., Newby P.K., Manson J.E., Meigs J.B., Rifai N., Willett W.C., Hu F.B. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 2005;82:163–173.
    1. Fito M., Guxens M., Corella D., Saez G., Estruch R., de la Torre R., Frances F., Cabezas C., Mdel C.L.-S., Marrugat J., et al. Effect of a traditional mediterranean diet on lipoprotein oxidation: A randomized controlled trial. Arch. Intern. Med. 2007;167:1195–1203. doi: 10.1001/archinte.167.11.1195.
    1. Tektonidis T.G., Akesson A., Gigante B., Wolk A., Larsson S.C. Adherence to a mediterranean diet is associated with reduced risk of heart failure in men. Eur. J. Heart Fail. 2016 doi: 10.1002/ejhf.481.
    1. Tektonidis T.G., Akesson A., Gigante B., Wolk A., Larsson S.C. A mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study. Atherosclerosis. 2015;243:93–98. doi: 10.1016/j.atherosclerosis.2015.08.039.
    1. Chrysohoou C., Panagiotakos D.B., Aggelopoulos P., Kastorini C.M., Kehagia I., Pitsavos C., Stefanadis C. The mediterranean diet contributes to the preservation of left ventricular systolic function and to the long-term favorable prognosis of patients who have had an acute coronary event. Am. J. Clin. Nutr. 2010;92:47–54. doi: 10.3945/ajcn.2009.28982.
    1. Chrysohoou C., Pitsavos C., Metallinos G., Antoniou C., Oikonomou E., Kotroyiannis I., Tsantilas A., Tsitsinakis G., Tousoulis D., Panagiotakos D.B., et al. Cross-sectional relationship of a mediterranean type diet to diastolic heart function in chronic heart failure patients. Heart Vessels. 2012;27:576–584. doi: 10.1007/s00380-011-0190-9.
    1. Fito M., Estruch R., Salas-Salvado J., Martinez-Gonzalez M.A., Aros F., Vila J., Corella D., Diaz O., Saez G., de la Torre R., et al. Effect of the mediterranean diet on heart failure biomarkers: A randomized sample from the predimed trial. Eur. J. Heart Fail. 2014;16:543–550. doi: 10.1002/ejhf.61.
    1. Bertoia M.L., Triche E.W., Michaud D.S., Baylin A., Hogan J.W., Neuhouser M.L., Tinker L.F., van Horn L., Waring M.E., Li W., et al. Mediterranean and dietary approaches to stop hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am. J. Clin. Nutr. 2014;99:344–351. doi: 10.3945/ajcn.112.056135.
    1. Chiuve S.E., Fung T.T., Rexrode K.M., Spiegelman D., Manson J.E., Stampfer M.J., Albert C.M. Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA. 2011;306:62–69. doi: 10.1001/jama.2011.907.
    1. Banke A., Schou M., Videbaek L., Moller J.E., Torp-Pedersen C., Gustafsson F., Dahl J.S., Kober L., Hildebrandt P.R., Gislason G.H. Incidence of cancer in patients with chronic heart failure: A long–term follow-up study. Eur. J. Heart Fail. 2016;18:260–266. doi: 10.1002/ejhf.472.
    1. Sofi F., Macchi C., Abbate R., Gensini G.F., Casini A. Mediterranean diet and health status: An updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17:2769–2782. doi: 10.1017/S1368980013003169.
    1. Diaz-Lopez A., Babio N., Martinez-Gonzalez M.A., Corella D., Amor A.J., Fito M., Estruch R., Aros F., Gomez-Gracia E., Fiol M., et al. Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: A post hoc analysis of a randomized trial. Diabetes Care. 2015;38:2134–2141. doi: 10.2337/dc15-1117.
    1. Sorli-Aguilar M., Martin-Lujan F., Santigosa-Ayala A., Pinol-Moreso J.L., Flores-Mateo G., Basora-Gallisa J., Arija-Val V., Sola-Alberich R. Effects of mediterranean diet on lung function in smokers: A randomised, parallel and controlled protocol. BMC Public Health. 2015;15:74. doi: 10.1186/s12889-015-1450-x.
    1. Levitan E.B., Lewis C.E., Tinker L.F., Eaton C.B., Ahmed A., Manson J.E., Snetselaar L.G., Martin L.W., Trevisan M., Howard B.V., et al. Mediterranean and dash diet scores and mortality in women with heart failure: The women’s health initiative. Circ. Heart Fail. 2013;6:1116–1123. doi: 10.1161/CIRCHEARTFAILURE.113.000495.
    1. Soukoulis V., Dihu J.B., Sole M., Anker S.D., Cleland J., Fonarow G.C., Metra M., Pasini E., Strzelczyk T., Taegtmeyer H., et al. Micronutrient deficiencies an unmet need in heart failure. J. Am. Coll. Cardiol. 2009;54:1660–1673. doi: 10.1016/j.jacc.2009.08.012.
    1. Carubelli V., Castrini A.I., Lazzarini V., Gheorghiade M., Metra M., Lombardi C. Amino acids and derivatives, a new treatment of chronic heart failure? Heart Fail. Rev. 2015;20:39–51. doi: 10.1007/s10741-014-9436-9.
    1. Lombardi C., Carubelli V., Lazzarini V., Vizzardi E., Bordonali T., Ciccarese C., Castrini A.I., dei Cas A., Nodari S., Metra M. Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition. 2015;31:72–78. doi: 10.1016/j.nut.2014.04.021.
    1. Lombardi C., Carubelli V., Lazzarini V., Vizzardi E., Quinzani F., Guidetti F., Rovetta R., Nodari S., Gheorghiade M., Metra M. Effects of oral amino acid supplements on functional capacity in patients with chronic heart failure. Clin. Med. Insights. Cardiol. 2014;8:39–44. doi: 10.4137/CMC.S14016.
    1. Bach-Faig A., Berry E.M., Lairon D., Reguant J., Trichopoulou A., Dernini S., Medina F.X., Battino M., Belahsen R., Miranda G., et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011;14:2274–2284. doi: 10.1017/S1368980011002515.
    1. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., Horan M.J., Labarthe D. Prevalence of hypertension in the us adult population. Results from the third national health and nutrition examination survey, 1988–1991. Hypertension. 1995;25:305–313. doi: 10.1161/01.HYP.25.3.305.
    1. Sacks F.M., Rosner B., Kass E.H. Blood pressure in vegetarians. Am. J. Epidemiol. 1974;100:390–398.
    1. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. Dash collaborative research group. N. Engl. J. Med. 1997;336:1117–1124. doi: 10.1056/NEJM199704173361601.
    1. Obarzanek E., Sacks F.M., Vollmer W.M., Bray G.A., Miller E.R., 3rd, Lin P.H., Karanja N.M., Most-Windhauser M.M., Moore T.J., Swain J.F., et al. Effects on blood lipids of a blood pressure-lowering diet: The dietary approaches to stop hypertension (DASH) trial. Am. J. Clin. Nutr. 2001;74:80–89.
    1. Svetkey L.P., Simons-Morton D., Vollmer W.M., Appel L.J., Conlin P.R., Ryan D.H., Ard J., Kennedy B.M. Effects of dietary patterns on blood pressure: Subgroup analysis of the dietary approaches to stop hypertension (DASH) randomized clinical trial. Arch. Intern. Med. 1999;159:285–293. doi: 10.1001/archinte.159.3.285.
    1. Ard J.D., Coffman C.J., Lin P.H., Svetkey L.P. One-year follow-up study of blood pressure and dietary patterns in dietary approaches to stop hypertension (DASH)-sodium participants. Am. J. Hypertens. 2004;17:1156–1162. doi: 10.1016/j.amjhyper.2004.07.005.
    1. Jacobs D.R., Jr., Gross M.D., Steffen L., Steffes M.W., Yu X., Svetkey L.P., Appel L.J., Vollmer W.M., Bray G.A., Moore T., et al. The effects of dietary patterns on urinary albumin excretion: Results of the dietary approaches to stop hypertension (DASH) trial. Am. J. Kidney Dis. 2009;53:638–646. doi: 10.1053/j.ajkd.2008.10.048.
    1. Chang A., van Horn L., Jacobs D.R., Jr., Liu K., Muntner P., Newsome B., Shoham D.A., Durazo-Arvizu R., Bibbins-Domingo K., Reis J., et al. Lifestyle-related factors, obesity, and incident microalbuminuria: The cardia (coronary artery risk development in young adults) study. Am. J. Kidney. Dis. 2013;62:267–275. doi: 10.1053/j.ajkd.2013.02.363.
    1. Svetkey L.P., Sacks F.M., Obarzanek E., Vollmer W.M., Appel L.J., Lin P.H., Karanja N.M., Harsha D.W., Bray G.A., Aickin M., et al. The DASH diet, sodium intake and blood pressure trial (DASH-sodium): Rationale and design. DASH-sodium collaborative research group. J. Am. Diet. Assoc. 1999;99:S96–S104. doi: 10.1016/S0002-8223(99)00423-X.
    1. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., 3rd, Simons-Morton D.G., et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-sodium collaborative research group. N. Engl. J. Med. 2001;344:3–10. doi: 10.1056/NEJM200101043440101.
    1. Carey V.J., Bishop L., Charleston J., Conlin P., Erlinger T., Laranjo N., McCarron P., Miller E., Rosner B., Swain J., et al. Rationale and design of the optimal macro-nutrient intake heart trial to prevent heart disease (omni-heart) Clin. Trials. 2005;2:529–537. doi: 10.1191/1740774505cn123oa.
    1. Appel L.J., Sacks F.M., Carey V.J., Obarzanek E., Swain J.F., Miller E.R., 3rd, Conlin P.R., Erlinger T.P., Rosner B.A., Laranjo N.M., et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the omniheart randomized trial. JAMA. 2005;294:2455–2464. doi: 10.1001/jama.294.19.2455.
    1. Conlin P.R., Erlinger T.P., Bohannon A., Miller E.R., 3rd, Appel L.J., Svetkey L.P., Moore T.J. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am. J. Hypertens. 2003;16:337–342. doi: 10.1016/S0895-7061(03)00056-6.
    1. Kirpizidis H., Stavrati A., Geleris P. Assessment of quality of life in a randomized clinical trial of candesartan only or in combination with DASH diet for hypertensive patients. J. Cardiol. 2005;46:177–182.
    1. Aljefree N., Ahmed F. Association between dietary pattern and risk of cardiovascular disease among adults in the middle east and north Africa region: A systematic review. Food Nutr. Res. 2015;59 doi: 10.3402/fnr.v59.27486.
    1. Fung T.T., Chiuve S.E., McCullough M.L., Rexrode K.M., Logroscino G., Hu F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008;168:713–720. doi: 10.1001/archinte.168.7.713.
    1. Mokhtari Z., Hosseini S., Miri R., Baghestani A.R., Zahedirad M., Rismanchi M., Nasrollahzadeh J. Relationship between dietary approaches to stop hypertension score and alternative healthy eating index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography. J. Hum. Nutr. Diet. 2015;28:350–356. doi: 10.1111/jhn.12311.
    1. Appel L.J., Champagne C.M., Harsha D.W., Cooper L.S., Obarzanek E., Elmer P.J., Stevens V.J., Vollmer W.M., Lin P.H., Svetkey L.P., et al. Effects of comprehensive lifestyle modification on blood pressure control: Main results of the premier clinical trial. JAMA. 2003;289:2083–2093.
    1. Parikh A., Lipsitz S.R., Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: Findings from a population-based follow-up study. Am. J. Hypertens. 2009;22:409–416. doi: 10.1038/ajh.2009.10.
    1. Levitan E.B., Wolk A., Mittleman M.A. Consistency with the DASH diet and incidence of heart failure. Arch. Intern. Med. 2009;169:851–857. doi: 10.1001/archinternmed.2009.56.
    1. Levitan E.B., Wolk A., Mittleman M.A. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am. J. Cardiol. 2009;104:1416–1420. doi: 10.1016/j.amjcard.2009.06.061.
    1. Salehi-Abargouei A., Maghsoudi Z., Shirani F., Azadbakht L. Effects of dietary approaches to stop hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—Incidence: A systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29:611–618. doi: 10.1016/j.nut.2012.12.018.
    1. Komajda M., Lam C.S. Heart failure with preserved ejection fraction: A clinical dilemma. Eur. Heart J. 2014;35:1022–1032. doi: 10.1093/eurheartj/ehu067.
    1. Hummel S.L., Seymour E.M., Brook R.D., Kolias T.J., Sheth S.S., Rosenblum H.R., Wells J.M., Weder A.B. Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction. Hypertension. 2012;60:1200–1206. doi: 10.1161/HYPERTENSIONAHA.112.202705.
    1. Hummel S.L., Seymour E.M., Brook R.D., Sheth S.S., Ghosh E., Zhu S., Weder A.B., Kovacs S.J., Kolias T.J. Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction. Circ. Heart Fail. 2013;6:1165–1171. doi: 10.1161/CIRCHEARTFAILURE.113.000481.
    1. Mathew A.V., Seymour E.M., Byun J., Pennathur S., Hummel S.L. Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction. J. Card. Fail. 2015;21:963–967. doi: 10.1016/j.cardfail.2015.10.003.
    1. Nguyen H.T., Bertoni A.G., Nettleton J.A., Bluemke D.A., Levitan E.B., Burke G.L. DASH eating pattern is associated with favorable left ventricular function in the multi-ethnic study of atherosclerosis. J. Am. Coll. Nutr. 2012;31:401–407. doi: 10.1080/07315724.2012.10720466.
    1. Rifai L., Pisano C., Hayden J., Sulo S., Silver M.A. Impact of the DASH diet on endothelial function, exercise capacity, and quality of life in patients with heart failure. Proceedings (Bayl. Univ. Med. Cent.) 2015;28:151–156.
    1. Akita S., Sacks F.M., Svetkey L.P., Conlin P.R., Kimura G., Group D.A.-S.T.C.R. Effects of the dietary approaches to stop hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension. 2003;42:8–13. doi: 10.1161/01.HYP.0000074668.08704.6E.
    1. Willcox D.C., Willcox B.J., Todoriki H., Suzuki M. The okinawan diet: Health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J. Am. Coll. Nutr. 2009;28:500S–516S. doi: 10.1080/07315724.2009.10718117.
    1. Rivas M., Garay R.P., Escanero J.F., Cia P., Jr., Cia P., Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr. 2002;132:1900–1902.
    1. Mori T.A. Dietary n-3 PUFA and CVD: A review of the evidence. Proc. Nutr. Soc. 2014;73:57–64. doi: 10.1017/S0029665113003583.
    1. Kuriyama S., Shimazu T., Ohmori K., Kikuchi N., Nakaya N., Nishino Y., Tsubono Y., Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The ohsaki study. JAMA. 2006;296:1255–1265. doi: 10.1001/jama.296.10.1255.
    1. Shimazu T., Kuriyama S., Hozawa A., Ohmori K., Sato Y., Nakaya N., Nishino Y., Tsubono Y., Tsuji I. Dietary patterns and cardiovascular disease mortality in Japan: A prospective cohort study. Int. J. Epidemiol. 2007;36:600–609. doi: 10.1093/ije/dym005.
    1. Niu K., Momma H., Kobayashi Y., Guan L., Chujo M., Otomo A., Ouchi E., Nagatomi R. The traditional Japanese dietary pattern and longitudinal changes in cardiovascular disease risk factors in apparently healthy Japanese adults. Eur. J. Nutr. 2016;55:267–279. doi: 10.1007/s00394-015-0844-y.
    1. Adamsson V., Reumark A., Cederholm T., Vessby B., Riserus U., Johansson G. What is a healthy nordic diet? Foods and nutrients in the nordiet study. Food Nutr. Res. 2012;56 doi: 10.3402/fnr.v56i0.18189.
    1. Adamsson V., Reumark A., Fredriksson I.B., Hammarstrom E., Vessby B., Johansson G., Riserus U. Effects of a healthy nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: A randomized controlled trial (nordiet) J. Intern. Med. 2011;269:150–159. doi: 10.1111/j.1365-2796.2010.02290.x.
    1. Poulsen S.K., Due A., Jordy A.B., Kiens B., Stark K.D., Stender S., Holst C., Astrup A., Larsen T.M. Health effect of the new Nordic diet in adults with increased waist circumference: A 6-mo randomized controlled trial. Am. J. Clin. Nutr. 2014;99:35–45. doi: 10.3945/ajcn.113.069393.
    1. Uusitupa M., Hermansen K., Savolainen M.J., Schwab U., Kolehmainen M., Brader L., Mortensen L.S., Cloetens L., Johansson-Persson A., Onning G., et al. Effects of an isocaloric healthy nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome—A randomized study (sysdiet) J. Intern. Med. 2013;274:52–66. doi: 10.1111/joim.12044.
    1. Olsen A., Egeberg R., Halkjaer J., Christensen J., Overvad K., Tjonneland A. Healthy aspects of the nordic diet are related to lower total mortality. J. Nutr. 2011;141:639–644. doi: 10.3945/jn.110.131375.
    1. Roswall N., Sandin S., Lof M., Skeie G., Olsen A., Adami H.O., Weiderpass E. Adherence to the healthy nordic food index and total and cause-specific mortality among Swedish women. Eur. J. Epidemiol. 2015;30:509–517. doi: 10.1007/s10654-015-0021-x.
    1. Roswall N., Li Y., Kyro C., Sandin S., Lof M., Adami H.O., Weiderpass E. No association between adherence to a healthy nordic food index and colorectal cancer: Results from a Swedish cohort study. Cancer Epidemiol. Biomark. Prev. 2015;24:755–757. doi: 10.1158/1055-9965.EPI-14-1314.
    1. Riserus U. Healthy nordic diet and cardiovascular disease. J. Intern. Med. 2015;278:542–544. doi: 10.1111/joim.12408.
    1. Wang F., Zheng J., Yang B., Jiang J., Fu Y., Li D. Effects of vegetarian diets on blood lipids: A systematic review and meta-analysis of randomized controlled trials. J. Am. Heart Assoc. 2015;4:e002408. doi: 10.1161/JAHA.115.002408.
    1. Dinu M., Abbate R., Gensini G.F., Casini A., Sofi F. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Crit. Rev. Food Sci. Nutr. 2016;0 doi: 10.1080/10408398.2016.1138447.
    1. Key T.J., Fraser G.E., Thorogood M., Appleby P.N., Beral V., Reeves G., Burr M.L., Chang-Claude J., Frentzel-Beyme R., Kuzma J.W., et al. Mortality in vegetarians and nonvegetarians: Detailed findings from a collaborative analysis of 5 prospective studies. Am. J. Clin. Nutr. 1999;70:516S–524S.
    1. Appleby P.N., Crowe F.L., Bradbury K.E., Travis R.C., Key T.J. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am. J. Clin. Nutr. 2016;103:218–230. doi: 10.3945/ajcn.115.119461.
    1. Jenkins D.J., Kendall C.W., Mehling C.C., Parker T., Rao A.V., Agarwal S., Novokmet R., Jones P.J., Raeini M., Story J.A., et al. Combined effect of vegetable protein (soy) and soluble fiber added to a standard cholesterol-lowering diet. Metabolism. 1999;48:809–816. doi: 10.1016/S0026-0495(99)90184-1.
    1. Jenkins D.J., Josse A.R., Wong J.M., Nguyen T.H., Kendall C.W. The portfolio diet for cardiovascular risk reduction. Curr. Atheroscler. Rep. 2007;9:501–507. doi: 10.1007/s11883-007-0067-7.
    1. Jenkins D.J., Kendall C.W., Marchie A., Faulkner D.A., Wong J.M., de Souza R., Emam A., Parker T.L., Vidgen E., Lapsley K.G., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and c-reactive protein. JAMA. 2003;290:502–510. doi: 10.1001/jama.290.4.502.
    1. Jenkins D.J., Jones P.J., Frohlich J., Lamarche B., Ireland C., Nishi S.K., Srichaikul K., Galange P., Pellini C., Faulkner D., et al. The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutr. Metab. Cardiovasc. Dis. 2015;25:1132–1139. doi: 10.1016/j.numecd.2015.08.006.
    1. Keith M., Kuliszewski M.A., Liao C., Peeva V., Ahmed M., Tran S., Sorokin K., Jenkins D.J., Errett L., Leong-Poi H. A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease. Clin. Nutr. 2015;34:541–548. doi: 10.1016/j.clnu.2014.06.010.
    1. Jenkins D.J., Wolever T.M., Taylor R.H., Barker H., Fielden H., Baldwin J.M., Bowling A.C., Newman H.C., Jenkins A.L., Goff D.V. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 1981;34:362–366.
    1. Ma X.Y., Liu J.P., Song Z.Y. Glycemic load, glycemic index and risk of cardiovascular diseases: Meta-analyses of prospective studies. Atherosclerosis. 2012;223:491–496. doi: 10.1016/j.atherosclerosis.2012.05.028.
    1. Dong J.Y., Zhang Y.H., Wang P., Qin L.Q. Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease. Am. J. Cardiol. 2012;109:1608–1613. doi: 10.1016/j.amjcard.2012.01.385.
    1. Sacks F.M., Carey V.J., Anderson C.A., Miller E.R., 3rd, Copeland T., Charleston J., Harshfield B.J., Laranjo N., McCarron P., Swain J., et al. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: The omnicarb randomized clinical trial. JAMA. 2014;312:2531–2541.
    1. Levitan E.B., Mittleman M.A., Wolk A. Dietary glycemic index, dietary glycemic load, and incidence of heart failure events: A prospective study of middle-aged and elderly women. J. Am. Coll. Nutr. 2010;29:65–71. doi: 10.1080/07315724.2010.10719818.
    1. Juanola-Falgarona M., Salas-Salvado J., Ibarrola-Jurado N., Rabassa-Soler A., Diaz-Lopez A., Guasch-Ferre M., Hernandez-Alonso P., Balanza R., Bullo M. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: A randomized controlled trial. Am. J. Clin. Nutr. 2014;100:27–35. doi: 10.3945/ajcn.113.081216.
    1. Arnold J.M., Liu P., Demers C., Dorian P., Giannetti N., Haddad H., Heckman G.A., Howlett J.G., Ignaszewski A., Johnstone D.E., et al. Canadian cardiovascular society consensus conference recommendations on heart failure 2006: Diagnosis and management. Can. J. Cardiol. 2006;22:23–45. doi: 10.1016/S0828-282X(06)70237-9.
    1. Elliott P., Stamler J., Nichols R., Dyer A.R., Stamler R., Kesteloot H., Marmot M. Intersalt revisited: Further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt cooperative research group. BMJ. 1996;312:1249–1253. doi: 10.1136/bmj.312.7041.1249.
    1. Zhou B.F., Stamler J., Dennis B., Moag-Stahlberg A., Okuda N., Robertson C., Zhao L., Chan Q., Elliott P., Group I.R. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: The intermap study. J. Hum. Hypertens. 2003;17:623–630. doi: 10.1038/sj.jhh.1001605.
    1. Cook N.R., Cutler J.A., Obarzanek E., Buring J.E., Rexrode K.M., Kumanyika S.K., Appel L.J., Whelton P.K. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP) BMJ. 2007;334:885–888. doi: 10.1136/bmj.39147.604896.55.
    1. He F.J., MacGregor G.A. Salt reduction lowers cardiovascular risk: Meta-analysis of outcome trials. Lancet. 2011;378:380–382. doi: 10.1016/S0140-6736(11)61174-4.
    1. Hooper L., Bartlett C., Davey Smith G., Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ. 2002;325:628. doi: 10.1136/bmj.325.7365.628.
    1. Taylor R.S., Ashton K.E., Moxham T., Hooper L., Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: A meta-analysis of randomized controlled trials (cochrane review) Am. J. Hypertens. 2011;24:843–853. doi: 10.1038/ajh.2011.115.
    1. Song E.K., Moser D.K., Dunbar S.B., Pressler S.J., Lennie T.A. Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure. Eur. J. Cardiovasc. Nurs. 2014;13:541–548. doi: 10.1177/1474515113517574.
    1. Doukky R., Avery E., Mangla A., Collado F.M., Ibrahim Z., Poulin M.F., Richardson D., Powell L.H. Impact of dietary sodium restriction on heart failure outcomes. JACC Heart Fail. 2016;4:24–35. doi: 10.1016/j.jchf.2015.08.007.
    1. Identifier nct02467296, nct02148679, nct01733017, and nct02012179. [(accessed on 8 June 2016)]; Available online: .
    1. Mellen P.B., Gao S.K., Vitolins M.Z., Goff D.C., Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988–1994 and 1999–2004. Arch. Intern. Med. 2008;168:308–314. doi: 10.1001/archinternmed.2007.119.
    1. Scourboutakos M.J., Semnani-Azad Z., L’Abbe M.R. Restaurant meals: Almost a full day’s worth of calories, fats, and sodium. JAMA Intern. Med. 2013;173:1373–1374. doi: 10.1001/jamainternmed.2013.6159.
    1. Young C.M., Batch B.C., Svetkey L.P. Effect of socioeconomic status on food availability and cost of the dietary approaches to stop hypertension (DASH) dietary pattern. J. Clin. Hypertens (Greenwich) 2008;10:603–611. doi: 10.1111/j.1751-7176.2008.08199.x.
    1. Monsivais P., Scarborough P., Lloyd T., Mizdrak A., Luben R., Mulligan A.A., Wareham N.J., Woodcock J. Greater accordance with the dietary approaches to stop hypertension dietary pattern is associated with lower diet-related greenhouse gas production but higher dietary costs in the United Kingdom. Am. J. Clin. Nutr. 2015;102:138–145. doi: 10.3945/ajcn.114.090639.
    1. Monsivais P., Rehm C.D., Drewnowski A. The DASH diet and diet costs among ethnic and racial groups in the United States. JAMA Intern. Med. 2013;173:1922–1924. doi: 10.1001/jamainternmed.2013.9479.
    1. Schroder H., Serra-Majem L., Subirana I., Izquierdo-Pulido M., Fito M., Elosua R. Association of increased monetary cost of dietary intake, diet quality and weight management in Spanish adults. Br. J. Nutr. 2016;115:817–822. doi: 10.1017/S0007114515005048.
    1. Algert S.J., Agrawal A., Lewis D.S. Disparities in access to fresh produce in low-income neighborhoods in Los Angeles. Am. J. Prev. Med. 2006;30:365–370. doi: 10.1016/j.amepre.2006.01.009.
    1. Bertoni A.G., Foy C.G., Hunter J.C., Quandt S.A., Vitolins M.Z., Whitt-Glover M.C. A multilevel assessment of barriers to adoption of dietary approaches to stop hypertension (DASH) among African Americans of low socioeconomic status. J. Health Care Poor Underserved. 2011;22:1205–1220. doi: 10.1353/hpu.2011.0142.
    1. Hu E.A., Toledo E., Diez-Espino J., Estruch R., Corella D., Salas-Salvado J., Vinyoles E., Gomez-Gracia E., Aros F., Fiol M., et al. Lifestyles and risk factors associated with adherence to the mediterranean diet: A baseline assessment of the predimed trial. PLoS ONE. 2013;8:363. doi: 10.1371/journal.pone.0060166.
    1. Wong M.C., Wang H.H., Kwan M.W., Fong B.C., Chan W.M., Zhang D.X., Li S.T., Yan B.P., Coats A.J., Griffiths S.M. Dietary counselling has no effect on cardiovascular risk factors among Chinese grade 1 hypertensive patients: A randomized controlled trial. Eur. Heart J. 2015;36:2598–2607. doi: 10.1093/eurheartj/ehv329.
    1. Deutch B., Dyerberg J., Pedersen H.S., Aschlund E., Hansen J.C. Traditional and modern greenlandic food—Dietary composition, nutrients and contaminants. Sci. Total Environ. 2007;384:106–119. doi: 10.1016/j.scitotenv.2007.05.042.
    1. Ziv A., Vogel O., Keret D., Pintov S., Bodenstein E., Wolkomir K., Doenyas K., Mirovski Y., Efrati S. Comprehensive approach to lower blood pressure (calm-bp): A randomized controlled trial of a multifactorial lifestyle intervention. J. Hum. Hypertens. 2013;27:594–600. doi: 10.1038/jhh.2013.29.
    1. Blumenthal J.A., Babyak M.A., Hinderliter A., Watkins L.L., Craighead L., Lin P.H., Caccia C., Johnson J., Waugh R., Sherwood A. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The encore study. Arch. Intern. Med. 2010;170:126–135. doi: 10.1001/archinternmed.2009.470.
    1. Konstantinidou V., Daimiel L., Ordovas J.M. Personalized nutrition and cardiovascular disease prevention: From framingham to predimed. Adv. Nutr. 2014;5:368S–371S. doi: 10.3945/an.113.005686.
    1. Ordovas J.M. Genetic interactions with diet influence the risk of cardiovascular disease. Am. J. Clin. Nutr. 2006;83:443S–446S.
    1. Shen J., Arnett D.K., Peacock J.M., Parnell L.D., Kraja A., Hixson J.E., Tsai M.Y., Lai C.Q., Kabagambe E.K., Straka R.J., et al. Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr. 2007;137:1846–1851.
    1. Garaulet M., Lee Y.C., Shen J., Parnell L.D., Arnett D.K., Tsai M.Y., Lai C.Q., Ordovas J.M. Clock genetic variation and metabolic syndrome risk: Modulation by monounsaturated fatty acids. Am. J. Clin. Nutr. 2009;90:1466–1475. doi: 10.3945/ajcn.2009.27536.
    1. Corella D., Carrasco P., Sorli J.V., Estruch R., Rico-Sanz J., Martinez-Gonzalez M.A., Salas-Salvado J., Covas M.I., Coltell O., Aros F., et al. Mediterranean diet reduces the adverse effect of the tcf7l2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: A randomized controlled trial in a high-cardiovascular-risk population. Diabetes Care. 2013;36:3803–3811. doi: 10.2337/dc13-0955.
    1. Palmer N.D., Hester J.M., An S.S., Adeyemo A., Rotimi C., Langefeld C.D., Freedman B.I., Ng M.C., Bowden D.W. Resequencing and analysis of variation in the tcf7l2 gene in African Americans suggests that snp rs7903146 is the causal diabetes susceptibility variant. Diabetes. 2011;60:662–668. doi: 10.2337/db10-0134.
    1. Ortega-Azorin C., Sorli J.V., Estruch R., Asensio E.M., Coltell O., Gonzalez J.I., Martinez-Gonzalez M.A., Ros E., Salas-Salvado J., Fito M., et al. Amino acid change in the carbohydrate response element binding protein is associated with lower triglycerides and myocardial infarction incidence depending on level of adherence to the mediterranean diet in the predimed trial. Circ. Cardiovasc. Genet. 2014;7:49–58. doi: 10.1161/CIRCGENETICS.113.000301.
    1. Castaner O., Corella D., Covas M.I., Sorli J.V., Subirana I., Flores-Mateo G., Nonell L., Bullo M., de la Torre R., Portoles O., et al. In vivo transcriptomic profile after a mediterranean diet in high-cardiovascular risk patients: A randomized controlled trial. Am. J. Clin. Nutr. 2013;98:845–853. doi: 10.3945/ajcn.113.060582.
    1. Chen Q., Turban S., Miller E.R., Appel L.J. The effects of dietary patterns on plasma renin activity: Results from the dietary approaches to stop hypertension trial. J. Hum. Hypertens. 2012;26:664–669. doi: 10.1038/jhh.2011.87.
    1. Naslund T., Silberstein D.J., Merrell W.J., Nadeau J.H., Wood A.J. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: Correlation with beta-receptor function in vitro. Clin. Pharmacol. Ther. 1990;48:87–95. doi: 10.1038/clpt.1990.121.
    1. Kopp U.C., DiBona G.F. Interaction between epinephrine and renal nerves in control of renin secretion rate. Am. J. Physiol. 1986;250:F999–F1007.
    1. Sun B., Williams J.S., Svetkey L.P., Kolatkar N.S., Conlin P.R. Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the dietary approaches to stop hypertension (DASH) dietary pattern. Am. J. Clin. Nutr. 2010;92:444–449. doi: 10.3945/ajcn.2009.28924.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe